The Cora pads lawsuit is an active federal class action accusing The Cora Company of marketing its menstrual pads and related feminine hygiene products as “100% organic,” “clean,” and “toxin-free” while independent lab testing reportedly detected PFAS — so-called forever chemicals — in the products. A parallel case targets Cora tampons on the same theory. As of mid-2026, both cases are still in litigation, and no settlement has been reached.
What the Lawsuit Alleges
Plaintiffs say third-party laboratory testing found PFAS in multiple Cora product lines, including pads, tampons, and panty liners, and that this contradicts the company’s marketing emphasizing organic ingredients and the absence of toxins. The complaints frame this as consumer fraud and false advertising: buyers paid a premium for products they believed were free of harmful chemicals because of how Cora labeled and promoted them.
The litigation runs on two tracks. The consumer fraud track does not require proof of any personal injury; a claimant only needs to show they purchased a misrepresented product. A separate personal injury track exists for people who believe PFAS exposure from Cora products contributed to specific health conditions, but that track requires medical documentation.
Where the Case Stands
The case is in discovery. Both sides are exchanging evidence, internal company documents, testing data, and deposition transcripts. Class certification proceedings are active, meaning the court is evaluating whether the case can proceed on behalf of all eligible consumers rather than only the named plaintiffs.
No settlement has been announced. Legal observers expect settlement discussions during the second half of 2026, and if talks fail, the case would move toward trial preparation. Experts have estimated a potential settlement fund between $5 million and $30 million, with projected individual payouts of $25 to $500 per claimant depending on proof of purchase and claim tier.
Who Would Be Covered
The eligible class generally includes U.S. consumers who purchased Cora pads, tampons, panty liners, or related feminine hygiene products between 2018 and 2025. There is no filing deadline yet. In cases like this one, claim deadlines are typically set 60 to 120 days after a court grants final approval of a settlement, so anyone who used Cora products in that window should hold onto receipts, order histories, or product photos in case a claims process opens.
What Testing Has Found in Cora Products
Mamavation included Cora in an October 2022 investigation of 23 tampon brands, though the specific lab results for individual products were not publicly disclosed on the site. In separate testing of Cora Period Underwear, an EPA-certified laboratory found fluorine at 14 and 13 parts per million. Those levels are relatively low and may suggest the chemicals were not intentionally added, but the detection led Mamavation to decline to recommend the brand.
The broader testing record helps explain why the case exists at all. Lab analyses commissioned by Mamavation and Environmental Health News between 2020 and 2022 found PFAS in 48 percent of sanitary pads, incontinence pads, and panty liners tested, 22 percent of tampons, and 65 percent of period underwear. Products marketed as “natural,” “organic,” or “non-toxic” were not spared: in one analysis, 13 of 22 products that tested positive carried such claims.
The EPA has linked PFAS exposure to decreased fertility, hormonal disruption, high blood pressure during pregnancy, increased risk of certain cancers, and reduced immune function. Researchers have flagged particular concern about menstrual products because the vaginal area is highly vascularized and the products sit in prolonged contact with sensitive tissue.
How This Case Fits a Larger Wave
The Cora litigation is one of several PFAS-related actions against feminine hygiene brands. The closest precedent is the Thinx class action, which settled in early 2023 for up to $5 million after plaintiffs alleged the company’s period underwear, marketed as “sustainable” and “organic,” contained PFAS. Thinx denied wrongdoing but agreed to change its marketing and take steps to prevent intentional PFAS addition. Knix Wear faces a proposed class action in the Northern District of California over “PFAS free” marketing. L. by Procter & Gamble faces a class action over its “100% organic” labeling, and LOLA faces a suit alleging tampon shedding defects.
Federal oversight has lagged. The FDA classifies tampons as Class II medical devices and pads as Class I, but does not require manufacturers to test for PFAS or heavy metals, and does not require ingredient disclosure. Its most recent industry guidance on menstrual products dates to 2005, and a 2022 bipartisan bill that would have required ingredient labeling did not advance.
States have moved faster. Vermont’s ban on intentionally added PFAS in menstrual products took effect January 1, 2026. Colorado, Maine, Connecticut, and Minnesota have enacted their own restrictions. New York, California, and Nevada require disclosure of intentionally added ingredients, though those laws may not reach contamination that occurs during manufacturing or packaging.